Axon Enterprise — Nov 4, 2025 release
Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001628280-25-048845
Showing in the filing
Remaining future contracted bookings expected to be fulfilled
“the remainder to be fulfilled over the following ten years”
Period
The long term
Measure
Company-defined measure
Source
Prose
All guidance in this release · 13
Annual growth for FY2025
“approximately 31%”
Revenue for FY2025
“approximately $2.74 billion”
Adjusted EBITDA margin for FY2025
“approximately 25%”
Axon Body Workforce Mini early deployments (… for FY2026
“first half of 2026”
Axon Body Workforce Mini general availability for FY2026
“by mid-year”
Future contracted bookings expected to be fu…
“between 20% to 25%”
Remaining future contracted bookings expecte… for the long term
“the remainder to be fulfilled over the following ten years”
Revenue for Q4 FY2025
“$750 million to $755 million”
Adjusted EBITDA for Q4 FY2025
“$178 million to $182 million”
Adjusted EBITDA margin (at midpoint) for Q4 FY2025
“approximately 24% Adjusted EBITDA margin at the midpoint”
Stock-based compensation expenses for FY2025
“approximately $580 million to $630 million”
Stock-based compensation expense related to … for FY2025
“approximately $330 million”
CapEx for FY2025
“$170 million to $180 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
This operational metric tracks our total unfulfilled contracted bookings for products and services, including remaining performance obligations, in addition to contracts with certain termination or other clauses as a result of which they are not otherwise included in remaining performance obligations. We expect to fulfill between 20% to 25% of this balance over the next 12 months and generally expect the remainder to be fulfilled over the following ten years. 2025 Outlook The following forward-looking statements reflect Axon’s expectations as of November 4, 2025 and are subject to risks and uncertainties. Please refer to “Forward-looking Statements” below for more information. Q4 2025 • We expect Q4 revenue of $750 million to $755 million, representing approximately 31% growth at the midpoint. • We expect Q4 Adjusted EBITDA of $178 million to $182 million, or approximately 24% Adjusted EBITDA margin at the midpoint. • We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent difficulty of forecasting certain types of expenses and gains such as stock-based compensation, income tax expenses and gains or losses on marketable securities and strategic investments, which affect net income but not Adjusted EBITDA. We are unable to reasonably estimate the impact of such expenses, which could be material, on net income. Accordingly, we do not provide forward-looking reconciliations of these measures. Full Year 2025 • Expected Q4 revenue implies full-year 2025 revenue of approximately $2.74 billion, representing approximately 31% annual growth. This is an increase from our prior revenue guidance range of $2.65 bi
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.